Elenco delle sostanze estremamente preoccupanti candidate all’autorizzazione
Elenco delle sostanze estremamente preoccupanti candidate all’autorizzazione
Elenco delle sostanze estremamente preoccupanti candidate all’autorizzazione
Filter the list
| Decisione | Insieme di dati IUCLID | ||||||
|---|---|---|---|---|---|---|---|
|
271-093-5
|
68515-50-4
|
16-giu-2014
|
Toxic for reproduction (Article 57c) |
 |
Details | ||
|
271-084-6
|
68515-42-4
|
20-giu-2011
|
Toxic for reproduction (Article 57c) |
|
Details | ||
|
276-158-1
|
71888-89-6
|
20-giu-2011
|
Toxic for reproduction (Article 57c) |
|
Details | ||
|
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
|
-
|
-
|
15-giu-2015
|
Toxic for reproduction (Article 57c) |
|
Details | |
|
202-486-1
|
96-18-4
|
20-giu-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
|
Details | ||
|
203-794-9
|
110-71-4
|
18-giu-2012
|
Toxic for reproduction (Article 57c) |
|
Details | ||
|
215-147-8
|
1306-23-6
|
16-dic-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
|
215-146-2
|
1306-19-0
|
20-giu-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | |
|
233-710-6
|
10325-94-7
|
15-gen-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
244-168-5
|
21041-95-2
|
15-gen-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
208-168-9
|
513-78-0
|
15-gen-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
231-152-8
|
7440-43-9
|
20-giu-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
|
-
|
-
|
19-dic-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | |
|
203-856-5
|
111-30-8
|
08-lug-2021
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | ||
|
EDA
|
203-468-6
|
107-15-3
|
27-giu-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | |
|
204-650-8
|
123-77-3
|
19-dic-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | ||
|
all possible combinations of the cis- and trans-isomers
|
-
|
-
|
19-dic-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | |
|
trimellitic anhydride; TMA
|
209-008-0
|
552-30-7
|
27-giu-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | |
|
X4261
|
401-850-9
|
255881-94-8
|
17-gen-2022
|
PBT (Article 57d) |
|
Details | |
|
and all major diastereoisomers identified
|
-
|
-
|
28-ott-2008
|
PBT (Article 57d) |
|
Details | |
|
200-268-0
|
56-35-9
|
28-ott-2008
|
PBT (Article 57d) |
|
Details | ||
|
204-371-1
|
120-12-7
|
28-ott-2008
|
PBT (Article 57d) |
|
Details | ||
|
232-140-5
|
7789-00-6
|
18-giu-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
213-103-2
|
924-42-5
|
10-giu-2022
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
200-879-2
|
75-56-9
|
19-dic-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
200-589-6
|
64-67-5
|
19-dic-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
215-607-8
|
1333-82-0
|
15-dic-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
201-173-7
|
79-06-1
|
30-mar-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
|
-
|
-
|
19-dic-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | |
|
-
|
423-400-0
|
59653-74-6
|
18-giu-2012
|
Mutagenic (Article 57b) |
|
Details | |
|
219-514-3
|
2451-62-9
|
18-giu-2012
|
Mutagenic (Article 57b) |
|
Details | ||
|
|
-
|
-
|
16-gen-2020
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
|
Details | |
|
203-615-4
|
108-78-1
|
17-gen-2023
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
|
Details | ||
|
covering any of their individual isomers and combinations thereof
|
-
|
-
|
16-lug-2019
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
|
Details | |
|
204-661-8
|
123-91-1
|
08-lug-2021
|
Carcinogenic (Article 57a) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
|
Details | ||
|
224-208-8
|
4247-02-3
|
17-gen-2023
|
Endocrine disrupting properties (Article 57(f) - human health) |
|
Details | ||
|
202-318-7
|
94-26-8
|
25-giu-2020
|
Endocrine disrupting properties (Article 57(f) - human health) |
|
Details | ||
|
201-025-1
|
77-40-7
|
08-lug-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
|
Details | ||
|
|
-
|
-
|
17-gen-2022
|
Endocrine disrupting properties (Article 57(f) - human health) |
|
Details | |
|
|
-
|
-
|
16-lug-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
|
-
|
-
|
15-gen-2018
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
201-280-9
|
80-46-6
|
12-gen-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | ||
|
202-679-0
|
98-54-4
|
16-lug-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | ||
|
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
|
799-990-1
|
-
|
20-giu-2013
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
|
-
|
-
|
19-dic-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
|
-
|
-
|
12-gen-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
covering well-defined substances and UVCB substances, polymers and homologues
|
-
|
-
|
19-dic-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
205-426-2
|
140-66-9
|
19-dic-2011
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | ||
|
3-benzylidene camphor; 3-BC
|
239-139-9
|
15087-24-8
|
15-gen-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
229-851-8
|
6786-83-0
|
18-giu-2012
|
Carcinogenic (Article 57a) |
|
Details | |